Compare eBay Inc (EBAY) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Neurocrine Biosciences Inc — how do they compare? eBay Inc trades at $111.7 (market cap $47.88B), while Neurocrine Biosciences Inc trades at $141.09 (market cap $14.60B). The key difference: eBay Inc is far larger — about 3.3× Neurocrine Biosciences Inc's market cap, and eBay Inc pays a 1.15% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Neurocrine Biosciences Inc for 23 Days on average.
| EBAY | NBIX | |
|---|---|---|
Market Cap | $47.88B | $14.60B |
Volume | 2,781,198 | 1,075,694 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $185.50 |
52-Week Low | $79.41 | $123.10 |
Typical Hold Time | 134 Days | 23 Days |
Enterprise Value | $51.71B | $14.61B |
Dividend Yield | 1.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.98, up 4.6% with bullish technical signals and strong earnings momentum after beating Q2 2026 estimates. The company maintains robust profitability with 72% gross margins and 47% ROE, while analyst consensus targets $117.68. Recent news highlights strategic focus on collectibles and live commerce growth, though GameStop's acquisition interest and executive selling warrant monitoring.
EBAY presents a balanced investment case with solid fundamentals and positive technicals, but faces competitive pressures from Amazon's multi-platform tools and potential acquisition uncertainty. The stock offers moderate upside to consensus targets with execution-dependent growth in key verticals.
Neurocrine Biosciences (NBIX) trades at $143.47, down 1.4% on the day, with a bearish technical signal but strong fundamentals including a 20.91% net income margin and consistent earnings beats. Recent news highlights pipeline advancements in Prader-Willi syndrome and executive appointments, while analyst consensus remains strongly bullish with a $204.18 price target.
The outlook is positive based on robust profitability and growth initiatives, though risks include execution of pipeline diversification and potential pricing pressure on key drug Ingrezza. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharma company with a deep pipeline, balanced by near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
